Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glucuronosyltransferase activity	UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.75e-05	35	100	4	GO:0015020
GeneOntologyBiologicalProcess	androgen metabolic process	SCARB1 UGT2B7 UGT2B10 UGT2B28 HSD17B4 UGT2B11	2.72e-08	38	100	6	GO:0008209
GeneOntologyBiologicalProcess	biphenyl catabolic process	UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.59e-08	8	100	4	GO:0070980
GeneOntologyBiologicalProcess	biphenyl metabolic process	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.07e-07	10	100	4	GO:0018879
GeneOntologyBiologicalProcess	xenobiotic glucuronidation	UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.50e-07	12	100	4	GO:0052697
GeneOntologyBiologicalProcess	cellular glucuronidation	UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.92e-06	21	100	4	GO:0052695
GeneOntologyBiologicalProcess	estrogen metabolic process	UGT2B7 UGT2B10 UGT2B28 HSD17B4 UGT2B11	5.25e-06	52	100	5	GO:0008210
GeneOntologyBiologicalProcess	glucuronate metabolic process	UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.16e-06	26	100	4	GO:0019585
GeneOntologyBiologicalProcess	uronic acid metabolic process	UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.16e-06	26	100	4	GO:0006063
GeneOntologyBiologicalProcess	benzene-containing compound metabolic process	UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.04e-05	37	100	4	GO:0042537
GeneOntologyBiologicalProcess	xenobiotic catabolic process	UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.04e-05	37	100	4	GO:0042178
GeneOntologyBiologicalProcess	hormone metabolic process	TPO SCARB1 KCNMA1 UGT2B7 UGT2B10 UGT2B28 HSD17B4 UGT2B11	7.65e-05	286	100	8	GO:0042445
GeneOntologyBiologicalProcess	Sertoli cell development	ATRX AKAP9 HSD17B4	2.08e-04	24	100	3	GO:0060009
GeneOntologyCellularComponent	nuclear outer membrane	SYNE2 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.44e-06	40	102	5	GO:0005640
HumanPheno	Pectus excavatum	ITCH NSD1 ADGRG1 DLK1 CREBBP NF1 SYNE2 HSD17B4 PUM1 VPS13B	6.20e-06	323	29	10	HP:0000767
HumanPheno	Abnormal sternum morphology	ITCH NSD1 ADGRG1 DLK1 CREBBP NF1 SYNE2 TTC21B HSD17B4 PUM1 VPS13B	2.95e-05	474	29	11	HP:0000766
Domain	PUM-HD	PUM2 PUM3 PUM1	1.53e-07	3	101	3	IPR033133
Domain	PUM_HD	PUM2 PUM3 PUM1	1.53e-07	3	101	3	PS50303
Domain	Pumilio_RNA-bd_rpt	PUM2 PUM3 PUM1	6.12e-07	4	101	3	IPR001313
Domain	PUM	PUM2 PUM3 PUM1	6.12e-07	4	101	3	PS50302
Domain	Pumilio	PUM2 PUM3 PUM1	6.12e-07	4	101	3	SM00025
Domain	UDPGT	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.49e-06	21	101	4	PF00201
Domain	UDPGT	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.49e-06	21	101	4	PS00375
Domain	UDP_glucos_trans	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.49e-06	21	101	4	IPR002213
Domain	Pumilio_RNA-bd	PUM2 PUM1	2.90e-05	2	101	2	IPR033712
Domain	Ribosomal_L3	RPL3 RPL3L	8.66e-05	3	101	2	IPR000597
Domain	RIBOSOMAL_L3	RPL3 RPL3L	8.66e-05	3	101	2	PS00474
Domain	PUF	PUM2 PUM1	8.66e-05	3	101	2	PF00806
Domain	Ribosomal_L3	RPL3 RPL3L	8.66e-05	3	101	2	PF00297
Domain	Ribosomal_L3_CS	RPL3 RPL3L	8.66e-05	3	101	2	IPR019926
Domain	ARM-type_fold	DOCK1 PUM2 NBEA SDAD1 CSE1L NF1 EIF5 PUM3 PUM1	9.27e-05	339	101	9	IPR016024
Domain	Biotin_lipoyl	ACACA DLAT	1.02e-03	9	101	2	PF00364
Domain	MYB_LIKE	EP400 RCOR3 MYBL1	1.13e-03	38	101	3	PS50090
Pathway	WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA	ATRX NSD1 ERBIN CREBBP MAGI2 MYBL1	1.88e-06	65	81	6	M39682
Pathway	REACTOME_PREDNISONE_ADME	UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.24e-06	23	81	4	MM16639
Pathway	REACTOME_GLUCURONIDATION	UGT2B7 UGT2B10 UGT2B28 UGT2B11	9.85e-06	24	81	4	MM14599
Pathway	REACTOME_GLUCURONIDATION	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.17e-05	25	81	4	M17787
Pathway	WP_GLUCURONIDATION	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.17e-05	25	81	4	MM15820
Pathway	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.17e-05	25	81	4	M605
Pathway	WP_GLUCURONIDATION	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.37e-05	26	81	4	M39404
Pathway	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.86e-05	28	81	4	M19580
Pathway	REACTOME_PARACETAMOL_ADME	UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.14e-05	39	81	4	MM15695
Pathway	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.71e-05	41	81	4	M7399
Pathway	REACTOME_ASPIRIN_ADME	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.15e-04	44	81	4	M45014
Pathway	REACTOME_ASPIRIN_ADME	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.26e-04	45	81	4	MM15694
Pathway	KEGG_DRUG_METABOLISM_OTHER_ENZYMES	UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.06e-04	51	81	4	M17726
Pathway	KEGG_STARCH_AND_SUCROSE_METABOLISM	UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.22e-04	52	81	4	M14171
Pathway	KEGG_STEROID_HORMONE_BIOSYNTHESIS	UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.76e-04	55	81	4	M14933
Pathway	REACTOME_HDL_CLEARANCE	SCARB1 HDLBP	3.22e-04	5	81	2	M27844
Pathway	KEGG_RETINOL_METABOLISM	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.95e-04	64	81	4	M9488
Pathway	REACTOME_MAJOR_PATHWAY_OF_RRNA_PROCESSING_IN_THE_NUCLEOLUS_AND_CYTOSOL	NOL6 KRR1 WDR43 RPL3 RPL3L RPL17	5.86e-04	180	81	6	MM15324
Pathway	REACTOME_EUKARYOTIC_TRANSLATION_INITIATION	EIF5 EIF3H RPL3 RPL3L RPL17	6.29e-04	120	81	5	M27686
Pathway	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	UGT2B7 UGT2B10 UGT2B28 UGT2B11	6.95e-04	70	81	4	M16794
Pathway	REACTOME_EUKARYOTIC_TRANSLATION_INITIATION	EIF5 EIF3H RPL3 RPL3L RPL17	7.03e-04	123	81	5	MM15415
Pathway	KEGG_DRUG_METABOLISM_CYTOCHROME_P450	UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.74e-04	72	81	4	M9257
Pathway	REACTOME_SIGNALING_BY_NOTCH1	ITCH NBEA DLK1 CREBBP	8.58e-04	74	81	4	M616
Pathway	REACTOME_RRNA_PROCESSING	NOL6 KRR1 WDR43 RPL3 RPL3L RPL17	1.15e-03	205	81	6	M27685
Pubmed	Human transcription factor protein interaction networks.	TET2 EP400 ATRX RBM33 PUM2 KRR1 ERBIN CREBBP SDAD1 RLF CSE1L BBX SYNE2 ZNF611 GMEB1 DLAT HELZ PUM3 RCOR3 ASXL2 EIF3H CPSF2 PUM1 RAI2	2.79e-12	1429	102	24	35140242
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ACACA NOL6 NSD1 KRR1 WDR43 ZC3H11A CSE1L NF1 SYNE2 OSBPL8 DLAT HELZ PUM3 PUM1 RPL3 HDLBP	8.47e-11	653	102	16	22586326
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DOCK1 UBR2 ITCH ACACA ATRX TM7SF3 NAIP ADGRG1 ACVR2B ERBIN MAP3K12 CREBBP RLF ZC3H11A SCARB1 TTC21B KCNMA1 RCOR3 GNAS RECK VPS13B RPAP2	3.01e-10	1489	102	22	28611215
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	EP400 ATRX RBM33 NOL6 NSD1 PUM2 ADGRG1 KRR1 ERBIN SDAD1 WDR43 ZC3H11A BBX EIF5 OSBPL8 HELZ PUM3 EIF3H MARK2 CPSF2 HDLBP	2.06e-09	1497	102	21	31527615
Pubmed	Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development.	UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.42e-09	7	102	4	26074487
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	H3-5 EP400 ATRX RBM33 NOL6 NSD1 KRR1 WDR43 ZC3H11A BBX SIMC1 EIF5 ZNF808 PUM3 PUM1 RPL17 HDLBP	2.64e-09	954	102	17	36373674
Pubmed	Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.84e-09	8	102	4	32093886
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	NOL6 PUM2 KRR1 ZC3H11A CSE1L DLAT PUM3 EIF3H CPSF2 HSD17B4 PUM1 RPL3 RPL3L RPL17	2.34e-08	714	102	14	28302793
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	ITCH CAPNS1 NOL6 EVPL KRR1 SDAD1 WDR43 ZC3H11A CSE1L FAM83F EIF5 PUM3 GNAS EIF3H MARK2 RPL3 RPL17 HDLBP	2.51e-08	1257	102	18	36526897
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	ACACA ATRX NOL6 KRR1 SDAD1 WDR43 ZC3H11A CSE1L NF1 EIF5 DLAT PUM3 GNAS EIF3H HSD17B4 PUM1 RPL3 RPL17 HDLBP	3.03e-08	1425	102	19	30948266
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	UBR2 EP400 PUM2 ERBIN MAGI2 ZC3H11A AKAP9 SYT11 ASXL2 PUM1 VPS13B	3.38e-08	407	102	11	12693553
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ITCH ACACA EP400 NOL6 KRR1 ERBIN CREBBP ZBED5 RLF ZC3H11A CSE1L NF1 DLAT PUM3 PUM1 RPL3 RPL17 HDLBP	7.61e-08	1353	102	18	29467282
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ITCH ANK2 ATRX DHRS13 RTN4IP1 ERBIN R3HCC1L AKAP9 SYNE2 OSBPL8 DLAT LSM4 GNAS MARK2 RPL3 VPS13B RPL17 HDLBP	3.07e-07	1487	102	18	33957083
Pubmed	ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ.	ACACA CAPNS1 NOL6 ZC3H11A CSE1L GNAS EIF3H RPL3 RPL3L RPL17 HDLBP RPAP2	3.12e-07	624	102	12	33729478
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	EP400 NOL6 WDR43 ZC3H11A CSE1L NF1 SYNE2 PUM3 GNAS MARK2 CPSF2 HSD17B4 PUM1 RPL3 HDLBP	3.13e-07	1024	102	15	24711643
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	ANK2 EP400 CAPNS1 NOL6 KRR1 SDAD1 WDR43 PRKD3 CSE1L AKAP9 OSBPL8 DLAT PUM3 GNAS MARK2 CPSF2 HDLBP	4.90e-07	1371	102	17	36244648
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	TET2 ACACA PUM2 CSE1L BBX HELZ PUM3 GNAS HSD17B4 PUM1 RPL3 RPL17	5.20e-07	655	102	12	35819319
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ACACA ANK2 EP400 ATRX PUM2 ERBIN WDR43 ZC3H11A R3HCC1L EIF5 HELZ RPL3 RPL17 HDLBP	6.13e-07	934	102	14	33916271
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	ACACA EP400 ATRX NOL6 SDAD1 NF1 PUM3 RPL3 RPL17 RPAP2	7.17e-07	440	102	10	34244565
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	ATRX RNF17 MAGI2 ZC3H11A SYNE2 HELZ PUM3 RPL3 RPAP2	1.16e-06	358	102	9	32460013
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	DOCK1 ATRX RNF17 MYO15B CSE1L NF1 GNAS MARK2 CPSF2 EXOC7 HDLBP	1.18e-06	582	102	11	20467437
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TET2 ITCH ACACA ERBIN NF1 AKAP9 SYNE2 EIF5 OSBPL8 HELZ GNAS MARK2 PUM1	1.48e-06	861	102	13	36931259
Pubmed	Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes.	UBR2 CREBBP CSE1L OSBPL8 DLAT PUM3 CPSF2 EXOC7 RPL3L RPAP2	3.97e-06	533	102	10	25544563
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	RBM33 PUM2 KRR1 ZC3H11A EIF5 HELZ LSM4 PUM3 PUM1 RPL3 RPL17 HDLBP	4.50e-06	807	102	12	22681889
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ITCH ANK2 ZNF618 NSD1 NBEA ERBIN ITIH4 MAGI2 NF1 AKAP9 SYNE2 KCNMA1 CPSF2	4.99e-06	963	102	13	28671696
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	TET2 ITCH ANK2 ATRX NBEA ADAMTS8 CREBBP ZBED5 MAGI2 FBH1 OSBPL8 DLAT HSD17B4 EXOC7 RECK	5.16e-06	1285	102	15	35914814
Pubmed	Tagging genes with cassette-exchange sites.	TM7SF3 PUM2 RNF17 CREBBP WDR43 CSE1L HELZ PUM1	6.81e-06	335	102	8	15741177
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	PUM2 KRR1 SDAD1 ZC3H11A BBX LSM4 CPSF2 PUM1 RPL3 RPL17 HDLBP	8.18e-06	713	102	11	29802200
Pubmed	Identification of a reciprocal negative feedback loop between tau-modifying proteins MARK2 kinase and CBP acetyltransferase.	CREBBP MARK2	8.52e-06	2	102	2	35469920
Pubmed	A novel ribosomal protein L3-like gene (RPL3L) maps to the autosomal dominant polycystic kidney disease gene region.	RPL3 RPL3L	8.52e-06	2	102	2	8921388
Pubmed	Cloning and comparative sequence analysis of PUM1 and PUM2 genes, human members of the Pumilio family of RNA-binding proteins.	PUM2 PUM1	8.52e-06	2	102	2	12459267
Pubmed	Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins.	PUM2 PUM1	8.52e-06	2	102	2	29165587
Pubmed	RPL3L-containing ribosomes determine translation elongation dynamics required for cardiac function.	RPL3 RPL3L	8.52e-06	2	102	2	37080962
Pubmed	PUMILIO-mediated translational control of somatic cell cycle program promotes folliculogenesis and contributes to ovarian cancer progression.	PUM2 PUM1	8.52e-06	2	102	2	35507203
Pubmed	Bespoke RNA recognition by Pumilios.	PUM2 PUM1	8.52e-06	2	102	2	26517885
Pubmed	Mouse Pum1 and Pum2 genes, members of the Pumilio family of RNA-binding proteins, show differential expression in fetal and adult hematopoietic stem cells and progenitors.	PUM2 PUM1	8.52e-06	2	102	2	12667987
Pubmed	Genome-wide comparison of human keratinocyte and squamous cell carcinoma responses to UVB irradiation: implications for skin and epithelial cancer.	PUM2 PUM1	8.52e-06	2	102	2	12771951
Pubmed	Alternate modes of cognate RNA recognition by human PUMILIO proteins.	PUM2 PUM1	8.52e-06	2	102	2	21397187
Pubmed	A divergent Pumilio repeat protein family for pre-rRNA processing and mRNA localization.	PUM3 PUM1	8.52e-06	2	102	2	25512524
Pubmed	A Quantitative and Predictive Model for RNA Binding by Human Pumilio Proteins.	PUM2 PUM1	8.52e-06	2	102	2	31078383
Pubmed	Quantitative analysis of UGT2B28 mRNA expression by real-time RT-PCR and application to human tissue distribution study.	UGT2B28 UGT2B11	8.52e-06	2	102	2	21679149
Pubmed	Regulatory domains of the A-Myb transcription factor and its interaction with the CBP/p300 adaptor molecules.	CREBBP MYBL1	8.52e-06	2	102	2	9210395
Pubmed	Principles of mRNA control by human PUM proteins elucidated from multimodal experiments and integrative data analysis.	PUM2 PUM1	8.52e-06	2	102	2	32753408
Pubmed	PUMILIO proteins promote colorectal cancer growth via suppressing p21.	PUM2 PUM1	8.52e-06	2	102	2	35338151
Pubmed	Effects of PUMILIO1 and PUMILIO2 knockdown on cardiomyogenic differentiation of human embryonic stem cells culture.	PUM2 PUM1	8.52e-06	2	102	2	32437472
Pubmed	Expression of Muscle-Specific Ribosomal Protein L3-Like Impairs Myotube Growth.	RPL3 RPL3L	8.52e-06	2	102	2	26684695
Pubmed	[TET2 and DLK1 gene expression and their clinical significance in bone marrow CD(3)(+) T cells of patients with myelodysplastic syndrome].	TET2 DLK1	8.52e-06	2	102	2	22943828
Pubmed	Comparative analysis of mRNA targets for human PUF-family proteins suggests extensive interaction with the miRNA regulatory system.	PUM2 PUM1	8.52e-06	2	102	2	18776931
Pubmed	A novel puf-A gene predicted from evolutionary analysis is involved in the development of eyes and primordial germ-cells.	PUM3 PUM1	8.52e-06	2	102	2	19319195
Pubmed	Characterization of RNP Networks of PUM1 and PUM2 Post-Transcriptional Regulators in TCam-2 Cells, a Human Male Germ Cell Model.	PUM2 PUM1	8.52e-06	2	102	2	32316190
Pubmed	Dynamic interplay between RPL3- and RPL3L-containing ribosomes modulates mitochondrial activity in the mammalian heart.	RPL3 RPL3L	8.52e-06	2	102	2	36882085
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	EP400 ATRX NOL6 KRR1 WDR43 ZC3H11A CSE1L RCOR3 EIF3H	1.03e-05	469	102	9	27634302
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	EP400 RBM33 NOL6 KRR1 ERBIN SDAD1 OSBPL8 CPSF2 HSD17B4	1.09e-05	472	102	9	38943005
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	UBR2 NBEA ERBIN SDAD1 CSE1L AKAP9 SYNE2 KCNMA1 HELZ CPSF2 HSD17B4 PUM1 HDLBP	1.24e-05	1049	102	13	27880917
Pubmed	The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.	NOL6 KRR1 SDAD1 WDR43 DLAT PUM3 MARK2 RPL3 RPL17	1.30e-05	483	102	9	36912080
Pubmed	A human MAP kinase interactome.	DOCK1 RBM33 EVPL ERBIN CREBBP CSE1L SIMC1 HELZ HDLBP	1.37e-05	486	102	9	20936779
Pubmed	Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant.	ACACA CAPNS1 CSE1L DLAT GNAS PUM1 RPL3 RPL17 HDLBP	1.41e-05	488	102	9	31324722
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	NOL6 KRR1 SDAD1 WDR43 ZC3H11A CSE1L DLAT PUM3 EIF3H MARK2 EXOC7	1.46e-05	759	102	11	35915203
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	ATRX MAP3K12 CREBBP SDAD1 GPATCH2L PRKD3 NF1 AKAP9 STK33 OSBPL8 EIF3H MARK2	1.50e-05	910	102	12	36736316
Pubmed	Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane.	DHRS13 SCARB1 SYNE2 EIF5 OSBPL8 RPL3 RPL17 HDLBP	1.54e-05	375	102	8	32788342
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	UBR2 ITCH ACACA ERBIN CSE1L AKAP9 DLAT RCOR3 GNAS MARK2 RPL3 RPL17 HDLBP RPAP2	1.69e-05	1247	102	14	27684187
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ACACA EP400 ATRX PUM2 ERBIN ZC3H11A NF1 HELZ MARK2 CPSF2 HDLBP	1.75e-05	774	102	11	15302935
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	GALNT1 ATRX NSD1 RTN4IP1 KRR1 ERBIN GPATCH2L ZC3H11A RCOR3 ASXL2 CPSF2 PUM1 VPS13B	1.75e-05	1084	102	13	11544199
Pubmed	The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.	EP400 NAIP OSBPL8 ASXL2 EIF3H CPSF2 HSD17B4	2.00e-05	281	102	7	24163370
Pubmed	The RNA-binding ubiquitin ligase MKRN1 functions in ribosome-associated quality control of poly(A) translation.	HELZ PUM1 RPL3 RPL17	2.12e-05	55	102	4	31640799
Pubmed	Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer-related pathways in breast cancer.	PRKD3 UGT2B10 UGT2B28 UGT2B11 RPL3L	2.44e-05	116	102	5	30652415
Pubmed	LncRNA MAGI2-AS3 is downregulated in non-small cell lung cancer and may be a sponge of miR-25.	MAGI2 RECK	2.55e-05	3	102	2	32138716
Pubmed	Antagonistic and cooperative AGO2-PUM interactions in regulating mRNAs.	PUM2 PUM1	2.55e-05	3	102	2	30333515
Pubmed	Human Pumilio proteins directly bind the CCR4-NOT deadenylase complex to regulate the transcriptome.	PUM2 PUM1	2.55e-05	3	102	2	33397688
Pubmed	NORAD: Defender of the Genome.	PUM2 PUM1	2.55e-05	3	102	2	27157388
Pubmed	cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily.	UGT2B10 UGT2B11	2.55e-05	3	102	2	8333863
Pubmed	The lipid transporter HDLBP promotes hepatocellular carcinoma metastasis through BRAF-dependent epithelial-mesenchymal transition.	ITCH HDLBP	2.55e-05	3	102	2	36122630
Pubmed	A novel function of human Pumilio proteins in cytoplasmic sensing of viral infection.	PUM2 PUM1	2.55e-05	3	102	2	25340845
Pubmed	PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells.	PUM2 PUM1	2.55e-05	3	102	2	28232582
Pubmed	Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300.	EP400 CREBBP	2.55e-05	3	102	2	9590171
Pubmed	Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins.	PUM2 PUM1	2.55e-05	3	102	2	26724866
Pubmed	Identification and characterization of RNA sequences to which human PUMILIO-2 (PUM2) and deleted in Azoospermia-like (DAZL) bind.	PUM2 SDAD1	2.55e-05	3	102	2	15607425
Pubmed	COP9 signalosome component CSN-5 stabilizes PUF proteins FBF-1 and FBF-2 in Caenorhabditis elegans germline stem and progenitor cells.	PUM2 PUM1	2.55e-05	3	102	2	38427913
Pubmed	Properties of the glucocorticoid modulatory element binding proteins GMEB-1 and -2: potential new modifiers of glucocorticoid receptor transactivation and members of the family of KDWK proteins.	CREBBP GMEB1	2.55e-05	3	102	2	10894151
Pubmed	Pumilio facilitates miRNA regulation of the E2F3 oncogene.	PUM2 PUM1	2.55e-05	3	102	2	22345517
Pubmed	Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor.	CSE1L NF1 EIF5 OSBPL8 DLAT EIF3H EXOC7 RPL3	2.81e-05	408	102	8	33766124
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	EP400 SDAD1 NF1 BBX DLAT PUM3 EIF3H MARK2	2.91e-05	410	102	8	26949251
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	ACACA EP400 NOL6 PUM2 KRR1 ITIH4 WDR43 OSBPL8 HELZ CPSF2 HSD17B4 PUM1 RPL3 RPL17	3.11e-05	1318	102	14	30463901
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	ACACA NOL6 KRR1 ERBIN SDAD1 WDR43 ZC3H11A DLAT PUM3 EIF3H RPL3 RPL17	3.38e-05	989	102	12	36424410
Pubmed	Nucleolar proteome dynamics.	ATRX NOL6 KRR1 SDAD1 PUM3 HSD17B4 RPL3 RPL17	3.39e-05	419	102	8	15635413
Pubmed	Directed proteomic analysis of the human nucleolus.	NOL6 KRR1 SDAD1 PUM3 RPL3 RPL17	3.56e-05	208	102	6	11790298
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	KRR1 SDAD1 CSE1L SIMC1 DLAT LSM4 GNAS EIF3H CPSF2 HSD17B4 RPL3 RPL17 HDLBP RPAP2	3.58e-05	1335	102	14	29229926
Pubmed	Defining the membrane proteome of NK cells.	ITCH GALNT1 DHRS13 KRR1 CSE1L NF1 OSBPL8 HELZ GNAS EIF3H CPSF2 EXOC7 RPL3L	3.80e-05	1168	102	13	19946888
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	ZC3H11A CSE1L SYNE2 GNAS MARK2 RPL3 RECK	4.76e-05	322	102	7	26514267
Pubmed	Mammalian Pum1 and Pum2 Control Body Size via Translational Regulation of the Cell Cycle Inhibitor Cdkn1b.	PUM2 PUM1	5.09e-05	4	102	2	30811992
Pubmed	Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.	UGT2B7 UGT2B10	5.09e-05	4	102	2	10024527
Pubmed	Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers.	NF1 GNAS	5.09e-05	4	102	2	29760048
Pubmed	Binding and modulation of p53 by p300/CBP coactivators.	EP400 CREBBP	5.09e-05	4	102	2	9194565
Pubmed	Functional interaction of CREB binding protein (CBP) with nuclear transport proteins and modulation by HDAC inhibitors.	CREBBP CSE1L	5.09e-05	4	102	2	16969114
Pubmed	Target RNA motif and target mRNAs of the Quaking STAR protein.	PUM2 PUM1	5.09e-05	4	102	2	16041388
Pubmed	Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.	SDAD1 ZC3H11A HELZ EIF3H RPL3 RPL17	5.24e-05	223	102	6	20020773
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	EP400 RBM33 PUM2 ERBIN OSBPL8 HELZ CPSF2 EXOC7 PUM1 RPAP2	6.06e-05	733	102	10	34672954
Pubmed	Functional proteomics mapping of a human signaling pathway.	ATRX ERBIN CREBBP ZBED5 RLF GMEB1 ASXL2 PUM1 HDLBP	6.27e-05	591	102	9	15231748
Pubmed	METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.	ACACA PUM2 DLAT GNAS RPL17 HDLBP	6.37e-05	231	102	6	36597993
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	ACACA CAPNS1 KRR1 CSE1L SYNE2 OSBPL8 DLAT LSM4 EIF3H HSD17B4 RPL3 RPL17 HDLBP RPAP2	6.69e-05	1415	102	14	28515276
Interaction	SIRT7 interactions	ACACA NOL6 NSD1 KRR1 WDR43 ZC3H11A CSE1L NF1 SYNE2 OSBPL8 DLAT HELZ PUM3 PUM1 RPL3 HDLBP	8.68e-07	744	101	16	int:SIRT7
Interaction	SMC5 interactions	H3-5 ACACA EP400 ATRX RBM33 NOL6 NSD1 KRR1 WDR43 ZC3H11A BBX SIMC1 EIF5 ZNF808 PUM3 PUM1 RPL17 HDLBP	2.15e-06	1000	101	18	int:SMC5
Interaction	UGT2B28 interactions	UGT2B10 UGT2B28 UGT2B11	2.42e-06	6	101	3	int:UGT2B28
Interaction	AATF interactions	NOL6 EVPL KRR1 SDAD1 WDR43 ZC3H11A PUM3 PUM1 RPL3 RPL17 HDLBP	2.92e-06	376	101	11	int:AATF
Interaction	HSF1 interactions	ACACA EP400 NOL6 RNF17 CREBBP ITIH4 ZC3H11A CSE1L SYNE2 HELZ PUM1 RPL3 HDLBP	1.10e-05	609	101	13	int:HSF1
Interaction	CCT8L2 interactions	ATRX RLF ZC3H11A SIMC1 HELZ HDLBP RPAP2	1.42e-05	157	101	7	int:CCT8L2
Interaction	RBM39 interactions	ACACA ATRX NOL6 PUM2 KRR1 ZC3H11A CSE1L DLAT LSM4 PUM3 EIF3H CPSF2 HSD17B4 PUM1 RPL3 RPL3L RPL17	1.55e-05	1042	101	17	int:RBM39
Interaction	KIF20A interactions	H3-5 ANK2 NOL6 DLK1 KRR1 ERBIN ITIH4 WDR43 SYNE2 HELZ PUM3 GNAS CPSF2 HSD17B4 RPL3 RPL3L RPL17	1.76e-05	1052	101	17	int:KIF20A
Interaction	BMI1 interactions	ACACA ATRX NOL6 NSD1 PUM2 EVPL KRR1 CREBBP ZC3H11A AKAP9 HELZ EIF3H PUM1	2.52e-05	659	101	13	int:BMI1
Interaction	FGFBP1 interactions	NOL6 KRR1 SDAD1 WDR43 BBX PUM3 RPL3 RPL17	4.56e-05	257	101	8	int:FGFBP1
Interaction	LIN28A interactions	NOL6 PUM2 KRR1 WDR43 ZC3H11A HELZ PUM3 PUM1 RPL3 RPL17	5.03e-05	421	101	10	int:LIN28A
Interaction	POLR1E interactions	NSD1 KRR1 CREBBP SDAD1 WDR43 RLF BBX RPL3 RPAP2	6.66e-05	350	101	9	int:POLR1E
Interaction	RHOB interactions	DOCK1 UBR2 ITCH NOL6 NBEA ERBIN PRKD3 CSE1L NF1 SCARB1 OSBPL8 GNAS MARK2 RPL3	7.57e-05	840	101	14	int:RHOB
Interaction	ANOS1 interactions	NOL6 NSD1 BBX PUM3 RPL3 RPL17	8.37e-05	143	101	6	int:ANOS1
Interaction	EED interactions	ACACA EP400 CAPNS1 NOL6 NSD1 KRR1 WDR43 ZC3H11A CSE1L TTC21B KCNMA1 PUM3 EIF3H MARK2 CPSF2 HSD17B4 RPL3 RPL17 HDLBP	9.05e-05	1445	101	19	int:EED
Interaction	CDC5L interactions	TET2 KRR1 RNF17 SDAD1 MYO15B CSE1L NF1 AKAP9 GNAS MARK2 CPSF2 EXOC7 RPL3 HDLBP	9.14e-05	855	101	14	int:CDC5L
Interaction	NUP42 interactions	PUM2 ZC3H11A HELZ MARK2 PUM1 RPL3	1.05e-04	149	101	6	int:NUP42
Interaction	PURG interactions	PUM2 KRR1 SDAD1 ZC3H11A HELZ PUM3 PUM1	1.32e-04	223	101	7	int:PURG
Interaction	YWHAG interactions	TET2 ITCH CAPNS1 KRR1 ERBIN CSE1L NF1 AKAP9 SYNE2 SIMC1 EIF5 KCNMA1 OSBPL8 HELZ GNAS MARK2 PUM1	1.47e-04	1248	101	17	int:YWHAG
Interaction	OBSL1 interactions	H3-5 EP400 NOL6 KRR1 SDAD1 WDR43 ZC3H11A SYNE2 ZNF611 DLAT PUM3 CPSF2 RPL3 HDLBP	1.60e-04	902	101	14	int:OBSL1
Interaction	RSBN1 interactions	NOL6 KRR1 BBX RPL3 RPL17 HDLBP	1.61e-04	161	101	6	int:RSBN1
Interaction	SPOUT1 interactions	ACACA SDAD1 WDR43 EIF3H RPL3 HDLBP	1.72e-04	163	101	6	int:SPOUT1
Interaction	RNF113A interactions	TET2 ACACA PUM2 CSE1L BBX HELZ PUM3 GNAS HSD17B4 PUM1 RPL3 RPL17	1.78e-04	692	101	12	int:RNF113A
Interaction	PABPC1 interactions	TET2 ITCH NSD1 PUM2 ZC3H11A R3HCC1L EIF5 HELZ PUM1 RPL3 RPL17 HDLBP	1.96e-04	699	101	12	int:PABPC1
Interaction	H2AB2 interactions	NOL6 KRR1 SDAD1 BBX RPL3	2.03e-04	107	101	5	int:H2AB2
Interaction	HERC2 interactions	H3-5 ANK2 NSD1 AKAP9 STK33 SYNE2 GNAS EIF3H MARK2 HDLBP	2.16e-04	503	101	10	int:HERC2
Interaction	PML interactions	TET2 ACACA EP400 ATRX CREBBP ZC3H11A CSE1L NF1 SYNE2 SIMC1 EIF5 DLAT RPL3 HDLBP	2.27e-04	933	101	14	int:PML
Cytoband	4q13.2	UGT2B10 UGT2B28 UGT2B11	4.57e-05	31	102	3	4q13.2
Cytoband	Ensembl 112 genes in cytogenetic band chr4q13	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.31e-04	157	102	4	chr4q13
GeneFamily	UDP glucuronosyltransferases	UGT2B7 UGT2B10 UGT2B28 UGT2B11	6.83e-06	32	70	4	363
GeneFamily	L ribosomal proteins	RPL3 RPL3L RPL17	1.01e-03	51	70	3	729
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	EP400 RCOR3 MYBL1	1.13e-03	53	70	3	532
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DOCK1 UBR2 ITCH GALNT1 ATRX PUM2 CREBBP WDR43 RLF CSE1L BBX AKAP9 SYNE2 OSBPL8 HELZ PUM3 PUM1 VPS13B MYBL1	7.48e-10	856	102	19	M4500
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	UBR2 EP400 ATRX RBM33 NSD1 PUM2 SLAMF1 ERBIN CREBBP ZBED5 PRKD3 ZC3H11A BBX AKAP9 EIF5 OSBPL8 HELZ ASXL2 GNAS EIF3H VPS13B MYBL1 RPL17	1.07e-08	1492	102	23	M40023
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	UBR2 ATRX PUM2 CREBBP WDR43 BBX AKAP9 OSBPL8 HELZ PUM3 PUM1 MYBL1	2.76e-07	466	102	12	M13522
Coexpression	PILON_KLF1_TARGETS_UP	PUM2 DLK1 SLAMF1 WDR43 UGT2B7 UGT2B10 DLAT ASXL2 UGT2B28 CPSF2 UGT2B11	8.57e-06	541	102	11	MM1061
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	GALNT1 TM7SF3 ADGRG1 KRR1 SDAD1 RLF BBX SYNE2 ZNF611 OSBPL8 PUM3 MYBL1	9.47e-06	656	102	12	M18979
Coexpression	GSE8835_CD4_VS_CD8_TCELL_UP	UBR2 ACACA NOL6 PRKD3 TTC21B ASXL2 PUM1	1.36e-05	200	102	7	M6254
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	ATRX PUM2 CREBBP BBX AKAP9 HELZ PUM1 VPS13B	2.32e-05	300	102	8	M8702
Coexpression	WENG_POR_TARGETS_LIVER_UP	UGT2B7 UGT2B10 UGT2B28 UGT2B11	5.47e-05	53	102	4	MM1203
Coexpression	ONKEN_UVEAL_MELANOMA_UP	WIPI1 ANK2 ADGRG1 MAP3K12 ZC3H11A NF1 AKAP9 SYNE2 PUM3 GNAS VPS13B RPL17	5.84e-05	790	102	12	M12490
Coexpression	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN	ATRX CREBBP AKAP9 RCOR3 MYBL1	6.28e-05	107	102	5	MM947
Coexpression	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN	ATRX CREBBP AKAP9 RCOR3 MYBL1	6.85e-05	109	102	5	M2451
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	UBR2 WIPI1 GALNT1 ACACA ATRX CAPNS1 PUM2 ERBIN GPATCH2L CSE1L SYNE2 OSBPL8 RCOR3 ASXL2 PUM1	7.11e-05	1215	102	15	M41122
Coexpression	MURARO_PANCREAS_BETA_CELL	ATRX NBEA DLK1 BBX SYT11 SYNE2 KCNMA1 OSBPL8 RCOR3 GNAS EIF3H RPL3 RPL17	7.80e-05	946	102	13	M39169
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	NF1 SH2D1B SYT11 UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.52e-05	267	102	7	MM984
Coexpression	SMID_BREAST_CANCER_BASAL_DN	ACACA NAIP NBEA OMD MAP3K12 NF1 KCNMA1 CATSPERB UGT2B11 EXOC7 RAI2	8.86e-05	699	102	11	M4960
Coexpression	GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP	ACACA NBEA RTN4IP1 NF1 GMEB1 VPS13B	1.24e-04	197	102	6	M7403
Coexpression	GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN	ERBIN ZBED5 ZC3H11A BBX AKAP9 VPS13B	1.27e-04	198	102	6	M7610
Coexpression	GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP	ERBIN CREBBP MYO15B AKAP9 RCOR3 RPL3	1.31e-04	199	102	6	M4526
Coexpression	GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	GALNT1 EP400 ATRX SLAMF1 PUM1 RPL17	1.31e-04	199	102	6	M8381
Coexpression	GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN	GALNT1 ZBED5 PRKD3 OSBPL8 GNAS HSD17B4	1.31e-04	199	102	6	M6172
Coexpression	GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN	WIPI1 ITCH ADGRG1 SYT11 SYNE2 MYBL1	1.34e-04	200	102	6	M4656
Coexpression	GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN	ERBIN RLF ZC3H11A RCOR3 MARK2 RAI2	1.34e-04	200	102	6	M7992
Coexpression	GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_UP	PRKD3 NF1 AKAP9 FAM83F KCNMA1 RECK	1.34e-04	200	102	6	M9073
Coexpression	GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP	RBM33 PRKD3 SCARB1 GMEB1 DLAT VPS13B	1.34e-04	200	102	6	M8491
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000	ITCH ATRX CREBBP RLF ZC3H11A SYNE2 GMEB1	6.44e-06	151	98	7	gudmap_developingGonad_P2_ovary_1000_k5
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000	DOCK1 ACACA ATRX NSD1 ACVR2B AKAP9 EIF5 ASXL2 VPS13B HDLBP	1.01e-05	379	98	10	gudmap_developingKidney_e15.5_1000_k3
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500	ITCH ATRX RNF17 RLF MAGI2 ZC3H11A SYNE2 GMEB1 PUM1 MYBL1	1.21e-05	387	98	10	gudmap_developingGonad_e16.5_ovary_500
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	ITCH ATRX DLK1 RNF17 CREBBP RLF MAGI2 ZC3H11A BBX SYNE2 GMEB1 ASXL2 PUM1 MYBL1	1.32e-05	778	98	14	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	DOCK1 WIPI1 ANK2 ZNF618 PUM2 ACVR2B BBX AKAP9 SYT11 KCNMA1 ASXL2 PUM1 VPS13B HDLBP	2.30e-05	818	98	14	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000	DOCK1 ATRX ZNF618 NSD1 ACVR2B AKAP9 EIF5 ASXL2 HDLBP	2.74e-05	339	98	9	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000	DOCK1 ITCH ACVR2B AKAP9 EIF5 ASXL2 VPS13B HDLBP	2.84e-05	261	98	8	gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000	ITCH ATRX CREBBP RLF ZC3H11A SYNE2 GMEB1	5.41e-05	210	98	7	gudmap_developingGonad_e18.5_ovary_1000_k2
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500	ITCH ATRX RLF ZC3H11A SYNE2 GMEB1	6.93e-05	150	98	6	gudmap_developingGonad_e12.5_epididymis_k5_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	DOCK1 ZNF618 PUM2 BBX AKAP9 ASXL2 PUM1 VPS13B HDLBP	7.33e-05	385	98	9	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	ITCH ATRX DLK1 RNF17 CREBBP RLF MAGI2 ZC3H11A BBX SYNE2 GMEB1 PUM1 MYBL1	7.35e-05	795	98	13	gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	ITCH ATRX ZNF618 DLK1 RNF17 CREBBP RLF ZC3H11A SYNE2 GMEB1 ASXL2 PUM1 MYBL1	8.23e-05	804	98	13	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000	ITCH ATRX CREBBP RLF ZC3H11A SYNE2 GMEB1	9.57e-05	230	98	7	gudmap_developingGonad_e16.5_ovary_1000_k2
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500	ITCH ATRX RNF17 RLF ZC3H11A SYNE2 GMEB1 PUM1 MYBL1	1.04e-04	403	98	9	gudmap_developingGonad_e12.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500	ITCH ATRX DLK1 RLF ZC3H11A SYNE2 GMEB1 PUM1 MYBL1	1.06e-04	404	98	9	gudmap_developingGonad_e18.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	ITCH ATRX DLK1 CREBBP RLF ZC3H11A SYNE2 GMEB1 PUM1	1.10e-04	406	98	9	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	ITCH ATRX DLK1 CREBBP RLF ZC3H11A SYNE2 GMEB1 PUM1	1.25e-04	413	98	9	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200	ITCH ATRX DLK1 ZC3H11A GMEB1 PUM1	1.25e-04	167	98	6	gudmap_developingGonad_e14.5_ epididymis_200
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000	ITCH ATRX ZNF618 CREBBP RLF ZC3H11A SYNE2 GMEB1	1.26e-04	323	98	8	gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500	ITCH ATRX DLK1 RLF ZC3H11A SYNE2 GMEB1 PUM1 MYBL1	1.34e-04	417	98	9	gudmap_developingGonad_e11.5_ovary + mesonephros_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500	ATRX CREBBP RLF SYNE2 GMEB1	1.38e-04	107	98	5	gudmap_developingGonad_e14.5_ epididymis_500_k2
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500	ITCH ATRX RLF ZC3H11A SYNE2 GMEB1	1.47e-04	172	98	6	gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500	ITCH ATRX RLF ZC3H11A GMEB1	1.51e-04	109	98	5	gudmap_developingGonad_e16.5_ovary_500_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000	DOCK1 PUM2 AKAP9 EIF5 ASXL2 HDLBP	1.52e-04	173	98	6	gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000	ITCH ATRX ZNF618 CREBBP ZC3H11A SYNE2 GMEB1	1.99e-04	259	98	7	gudmap_developingGonad_e12.5_epididymis_k3_1000
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000	ITCH ATRX RNF17 CREBBP RLF ZC3H11A BBX SYNE2 GMEB1 FAM47E PUM1 MYBL1	2.21e-04	770	98	12	gudmap_developingGonad_P2_ovary_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	ITCH ATRX RNF17 RLF MAGI2 ZC3H11A BBX SYNE2 GMEB1 ASXL2 PUM1 MYBL1	2.38e-04	776	98	12	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_500	ATRX RLF SYNE2 MYBL1	2.62e-04	67	98	4	gudmap_developingGonad_e18.5_epididymis_500_k3
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	ITCH ATRX ZNF618 NBEA DLK1 CREBBP RLF ZC3H11A SYNE2 GMEB1 PUM1 MYBL1	2.80e-04	790	98	12	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000	ITCH ATRX CREBBP RLF SYNE2 GMEB1 MYBL1	2.87e-04	275	98	7	gudmap_developingGonad_e14.5_ epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000	ITCH ATRX ZNF618 CREBBP ZC3H11A SYNE2 GMEB1	3.00e-04	277	98	7	gudmap_developingGonad_e12.5_ovary_k3_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000	ATRX CREBBP RLF SYNE2 MYBL1	3.08e-04	127	98	5	gudmap_developingGonad_e16.5_epididymis_1000_k4
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	ITCH ATRX ZNF618 NBEA DLK1 CREBBP RLF ZC3H11A SYNE2 GMEB1 PUM1 MYBL1	3.17e-04	801	98	12	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	ITCH ATRX ZNF618 RNF17 CREBBP RLF ZC3H11A BBX SYNE2 GMEB1 PUM1 MYBL1	3.35e-04	806	98	12	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000	GALNT1 ACACA ATRX PUM2 ADGRG1 DLK1 RNF17 PRKD3 BBX SCARB1 SYNE2 PUM1	3.87e-04	819	98	12	gudmap_developingGonad_P2_testes_1000
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500	ATRX DLK1 RNF17 RLF ZC3H11A SYNE2 PUM1 MYBL1	4.27e-04	387	98	8	gudmap_developingGonad_e18.5_ovary_500
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500	ITCH ATRX RNF17 RLF ZC3H11A SYNE2 GMEB1 PUM1	6.15e-04	409	98	8	gudmap_developingGonad_e12.5_ovary_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_100	ITCH ATRX DLK1 ZC3H11A	6.20e-04	84	98	4	gudmap_developingGonad_e14.5_ epididymis_100
CoexpressionAtlas	DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_500	ATRX PUM2 ADGRG1 DLK1 RNF17 BBX SCARB1 PUM1	6.35e-04	411	98	8	gudmap_developingGonad_e14.5_ testes_500
CoexpressionAtlas	DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_1000	DOCK1 ACVR2B EIF5 ASXL2 HDLBP	7.00e-04	152	98	5	gudmap_developingKidney_e15.5_S-shaped body_1000_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500	DOCK1 NSD1 PUM2 RLF ASXL2 HDLBP	7.11e-04	231	98	6	gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#2_top-relative-expression-ranked_200	DOCK1 WIPI1 AKAP9 HDLBP	7.39e-04	88	98	4	gudmap_developingKidney_e15.5_200_k2
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500	DOCK1 AKAP9 EIF5 ASXL2 HDLBP	7.87e-04	156	98	5	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000	DOCK1 ATRX NSD1 CREBBP RLF AKAP9 ASXL2	8.49e-04	330	98	7	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_200	ATRX RNF17 ZC3H11A GMEB1 MYBL1	8.57e-04	159	98	5	gudmap_developingGonad_e12.5_epididymis_200
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000	DOCK1 ATRX ADAMTS8 MAP3K12 AKAP9 EIF5 KCNMA1 OSBPL8 ASXL2 MYBL1 HDLBP	8.62e-04	772	98	11	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500	ITCH ATRX RLF ZC3H11A GMEB1	9.07e-04	161	98	5	gudmap_developingGonad_e12.5_ovary_k3_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500	ITCH ATRX CREBBP ZC3H11A GMEB1	9.32e-04	162	98	5	gudmap_developingGonad_e16.5_epididymis_500_k2
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_500	DOCK1 AKAP9 EIF5 HDLBP	9.47e-04	94	98	4	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k4
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000	DOCK1 ITCH ACVR2B AKAP9 FAM83F EIF5 UGT2B10 HELZ ASXL2 VPS13B HDLBP	9.98e-04	786	98	11	gudmap_developingKidney_e15.5_Medullary collecting duct_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500	PUM2 NBEA MAGI2 ASXL2 CPSF2 RAI2	1.01e-03	247	98	6	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200	ITCH ATRX DLK1 ZC3H11A SYNE2	1.04e-03	166	98	5	gudmap_developingGonad_e18.5_epididymis_200
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000	ITCH ATRX CREBBP ZC3H11A SYNE2 GMEB1	1.05e-03	249	98	6	gudmap_developingGonad_P2_epididymis_1000_k3
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000	DOCK1 WIPI1 ACACA ATRX NSD1 ACVR2B AKAP9 EIF5 ASXL2 VPS13B HDLBP	1.09e-03	795	98	11	gudmap_developingKidney_e15.5_anlage of loop of Henle_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	ITCH ATRX DLK1 CREBBP RLF ZC3H11A SYNE2 GMEB1 RCOR3 PUM1 MYBL1	1.14e-03	799	98	11	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500	ITCH ATRX RLF SYNE2	1.24e-03	101	98	4	gudmap_developingGonad_e14.5_ ovary_500_k1
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000	ITCH ATRX ZNF618 DLK1 CREBBP RLF ZC3H11A SYNE2 GMEB1 PUM1 MYBL1	1.34e-03	815	98	11	gudmap_developingGonad_e11.5_ovary + mesonephros_1000
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK1 UBR2 ACACA NBEA MAGI2 NF1 KCNMA1 VPS13B	1.95e-08	199	102	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	H3-5 ADGRG1 ERBIN ZC3H11A SYNE2 MYBL1 PDZD4	1.75e-07	177	102	7	d3e6c768b88b7906f3c7fdd00ba20842212c14b1
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	H3-5 ADGRG1 ERBIN ZC3H11A SYNE2 MYBL1 PDZD4	1.75e-07	177	102	7	f8f101c772c043636bedd6b2ec81409b1d2599bf
ToppCell	COVID-19_Mild-Lymphoid_T/NK-NK_activated\|COVID-19_Mild / Disease group, lineage and cell class	H3-5 ADGRG1 ERBIN ZC3H11A SYNE2 MYBL1 PDZD4	1.75e-07	177	102	7	6978a22fef40c8b455342373abe7593f5ede0fa4
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	H3-5 ADGRG1 ERBIN ZC3H11A SYNE2 MYBL1 PDZD4	1.75e-07	177	102	7	936ab2b180a052387124f68d0c7f41c0b164e748
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	H3-5 ADGRG1 ERBIN ZC3H11A SYNE2 MYBL1 PDZD4	1.75e-07	177	102	7	d5aeda113afaa2425874394610344570c9078478
ToppCell	COVID-19_Severe-gd_T\|COVID-19_Severe / Disease condition and Cell class	ADGRG1 ERBIN ZC3H11A SYT11 SYNE2 MYBL1 PDZD4	2.27e-07	184	102	7	791f1bcb954aadc63d4117c400537d036f68734d
ToppCell	COVID-19_Severe-Lymphoid_T/NK-gd_T\|COVID-19_Severe / Disease group, lineage and cell class	ADGRG1 ERBIN ZC3H11A SYT11 SYNE2 MYBL1 PDZD4	3.36e-07	195	102	7	9990440bda7fac5d00ef80444fab07459be625e1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ADGRG1 ERBIN ZC3H11A SYT11 SYNE2 MYBL1 PDZD4	3.48e-07	196	102	7	418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADGRG1 ERBIN ZC3H11A SYT11 SYNE2 MYBL1 PDZD4	3.48e-07	196	102	7	581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ADGRG1 ERBIN ZC3H11A SYT11 SYNE2 MYBL1 PDZD4	3.48e-07	196	102	7	6beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADGRG1 ERBIN ZC3H11A SYT11 SYNE2 MYBL1 PDZD4	3.48e-07	196	102	7	c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	GALNT1 ATRX ZC3H11A AKAP9 SYNE2 OSBPL8 RPL17	3.86e-07	199	102	7	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	TET2 ATRX ZC3H11A BBX AKAP9 SYNE2 OSBPL8	3.86e-07	199	102	7	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 UBR2 ATRX RBM33 AKAP9 SYNE2 HELZ	3.99e-07	200	102	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	H3-5 ZC3H11A SH2D1B SYT11 SYNE2 MYBL1 PDZD4	3.99e-07	200	102	7	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	COVID-19_Mild-gd_T\|COVID-19_Mild / Disease condition and Cell class	ITCH ADGRG1 ERBIN SYNE2 MYBL1 PDZD4	4.06e-06	183	102	6	f593a89b0aa8fffdfa403769916facfd30358521
ToppCell	mild_COVID-19-CD4+_CTL\|mild_COVID-19 / disease group, cell group and cell class (v2)	ADGRG1 SLAMF1 SYNE2 RPL3 MYBL1 PDZD4	4.60e-06	187	102	6	49196d07e4716c87d33229a4569bdb6b4613b3eb
ToppCell	ASK428-Immune-NK_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	ADGRG1 SH2D1B SYNE2 ZNF808 MYBL1 PDZD4	5.04e-06	190	102	6	d649f7e17c4227787465dfc02037f791ff85378b
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	RBM33 DLK1 ERBIN AKAP9 HELZ PUM1	5.51e-06	193	102	6	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX NSD1 DLK1 AKAP9 SCARB1 EIF5	5.68e-06	194	102	6	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	ADGRG1 SYT11 SYNE2 RPL3 MYBL1 PDZD4	6.02e-06	196	102	6	af00c31612e4fe068e5fccae05368edba46bbd20
ToppCell	severe-Lymphocytic-NK_cells\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ADGRG1 SH2D1B SYNE2 RPL3 MYBL1 PDZD4	6.20e-06	197	102	6	8bf88b10d49ac499e7d0ba5b7023909e1fd7b29a
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	ATRX ADGRG1 ZC3H11A AKAP9 SYNE2 HDLBP	6.38e-06	198	102	6	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	UBR2 ATRX AKAP9 SYNE2 VPS13B MYBL1	6.57e-06	199	102	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	GALNT1 ATRX BBX AKAP9 SYNE2 RPL17	6.57e-06	199	102	6	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	GALNT1 ATRX ZC3H11A AKAP9 SYNE2 OSBPL8	6.57e-06	199	102	6	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	Control-Control-Myeloid-immature_Neutrophil\|Control / Disease, condition lineage and cell class	GALNT1 RLF MYO15B CSE1L R3HCC1L HDLBP	6.76e-06	200	102	6	118321ac443feb42aee171baccfc4610f00a8822
ToppCell	healthy_donor\|World / Disease condition, Lineage, Cell class and subclass	ADGRG1 SH2D1B SYNE2 RPL3 MYBL1 PDZD4	6.76e-06	200	102	6	afd4d5609adaa470e3d880f8be4a4d55e162b3d6
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	ZNF618 ZC3H11A AKAP9 SYNE2 GNAS	1.66e-05	138	102	5	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	EVPL MAGI2 KCNMA1 UGT2B28 UGT2B11	2.64e-05	152	102	5	32634195048858ae84605c61e43c542d90f7cab5
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	EVPL MAGI2 KCNMA1 UGT2B28 UGT2B11	2.64e-05	152	102	5	0eb185b2404f015efff1bd140e0c502d714720fb
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG1 XPNPEP2 SYT11 SYNE2 MYBL1	3.58e-05	162	102	5	f0a92c92c3a6cf9fa11fb279a584e7f328cb7d43
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	4.37e-05	169	102	5	e9c0e0f4c421c7bdbf1a7e33002f3cf22ea307cb
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	4.37e-05	169	102	5	d375a1df1ecc938f66bad92e54b8cda26ca9c472
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	4.37e-05	169	102	5	58f805c0be507bd5fadc9ea3555032daabbc8ab8
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	4.76e-05	172	102	5	86f52f486d67217fc1b8443ab362c975df2974a4
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	4.76e-05	172	102	5	fb2df8fea6df5947165f13978f1d1006d15b60fd
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	4.76e-05	172	102	5	e38ebb216e4ddcd008148fcbaf709b4f3c83706a
ToppCell	COVID-19_Severe-CD4+_CTL\|COVID-19_Severe / disease group, cell group and cell class	TPO ADGRG1 SYNE2 CATSPERB MYBL1	5.45e-05	177	102	5	34e9455790bae905dd91923792f4109d18b7686e
ToppCell	ASK428-Immune-NK_cell\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	5.90e-05	180	102	5	857d09446e3e6737e83d0f10bfda2ba282d5ba75
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	H3-5 ZNF618 EVPL RNF17 CLEC4F	6.38e-05	183	102	5	bd78e5c2670e67b4363078e3ca5a5b7081d24b7e
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	H3-5 ZNF618 EVPL RNF17 CLEC4F	6.38e-05	183	102	5	d1bf3abf42eb9d7facf775becf1338d1faadd647
ToppCell	COVID-19_Mild-NK_activated\|COVID-19_Mild / Disease condition and Cell class	H3-5 ADGRG1 ERBIN ZC3H11A FBH1	6.38e-05	183	102	5	22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f
ToppCell	Control-Lymphocyte-T_NK-CD4_TEM\|Control / Disease, Lineage and Cell Type	SLAMF1 SYNE2 RPL3 MYBL1 RPL17	6.72e-05	185	102	5	8d6a089dcb4bfb0e74b6316fb7221688c1835e6e
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	ADGRG1 ACVR2B BBX AKAP9 SYNE2	6.72e-05	185	102	5	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ATRX ERBIN CREBBP ASXL2 VPS13B	6.89e-05	186	102	5	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	ASK440-Immune-NK_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	6.89e-05	186	102	5	ce8e63057a99afa0a9cbf27ae7f9a70c0e972b6d
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG1 SYNE2 MYBL1 PDZD4 RPL17	7.07e-05	187	102	5	cfdc1585c80d2bb475d9145395fb50a88c53f838
ToppCell	Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADGRG1 SH2D1B SYNE2 MYBL1 RPAP2	7.07e-05	187	102	5	6981b856187a2e689260ecb7d0a1193a374ee9b9
ToppCell	ILEUM-non-inflamed-(5)_Plasma-(5)_IgG_plasma_cells\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RBM33 ZC3H11A SYNE2 EIF5 RPL17	7.25e-05	188	102	5	2156f1bc849ff1cb09ae296d13bedd913ae6b43b
ToppCell	COVID-19-T_cells-NK_cells\|COVID-19 / group, cell type (main and fine annotations)	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	7.43e-05	189	102	5	b699152dfbb8cd8ed724e1e5a51838f29b681b62
ToppCell	(210)_NKT_cell\|World / immune cells in Peripheral Blood (logTPM normalization)	ADGRG1 SH2D1B SYT11 SYNE2 MYBL1	8.00e-05	192	102	5	08dc0c019c594da7b9944db8fd706aa7780e6ae9
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	RBM33 DLK1 AKAP9 HELZ PUM1	8.00e-05	192	102	5	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG1 SH2D1B MYBL1 PDZD4 RPL17	8.00e-05	192	102	5	c5f77c2103841505d13e09173549811312ef2f01
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG1 SH2D1B MYBL1 PDZD4 RPL17	8.00e-05	192	102	5	e981162f387a31111c0ae8355dbe9db5785c4838
ToppCell	(21)_NKT_cell\|World / immune cells in Peripheral Blood (logTPM normalization)	ADGRG1 SH2D1B SYT11 SYNE2 MYBL1	8.00e-05	192	102	5	b0a573ddde2978485a857b8261ee1ee5ef68ecef
ToppCell	ASK452-Immune-NK_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	8.00e-05	192	102	5	f04ee5aaa54c39b7493098fb3d2f78168d6b8060
ToppCell	ASK454-Immune-T_cell\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	SLAMF1 SYNE2 RPL3 MYBL1 RPL17	8.20e-05	193	102	5	27c38a364bcdb4c0967155f18aa81d37e17c920b
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ATRX AKAP9 ASXL2 PUM1 VPS13B	8.20e-05	193	102	5	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Control\|World / Disease condition and Cell class	ADGRG1 ERBIN SH2D1B RPL3 PDZD4	8.20e-05	193	102	5	92347e919c8425f33692e121df6ca5d841748f6c
ToppCell	ASK454-Immune-T_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	SLAMF1 SYNE2 RPL3 MYBL1 RPL17	8.20e-05	193	102	5	11e1db416dc9a0b99ddb72d6021fba6e25405b5c
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	8.40e-05	194	102	5	8bfd7c5be518b81b17913139bcb3ebea01f48dd5
ToppCell	droplet-Tongue-nan-3m-Epithelial-basal_cell\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAPNS1 GNAS EIF3H RPL3 RPL17	8.40e-05	194	102	5	1eef012e53e43c4f4f6968baac3cc28727c4a9b5
ToppCell	ICU-SEP-Lymphocyte-T_NK-CD4_CTL\|ICU-SEP / Disease, Lineage and Cell Type	ADGRG1 SLAMF1 SYNE2 RPL3 MYBL1	8.40e-05	194	102	5	ca7f5ae54313b3728d6e6e4f801dc420d5406930
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	ADGRG1 SYT11 SYNE2 MYBL1 PDZD4	8.40e-05	194	102	5	ecdfc27d06e363fb23f0309f26ef6404a89f14ec
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	8.40e-05	194	102	5	f0707601883b234ed477c7704ca9a88efaefc3fd
ToppCell	COVID-19_Severe-CD8+_Tem\|COVID-19_Severe / Disease condition and Cell class	ADGRG1 ERBIN SYNE2 MYBL1 PDZD4	8.61e-05	195	102	5	ff7ae62393e1c858a10592db8e6d9f36b8bae396
ToppCell	mild_COVID-19-CD4+_CTL\|World / disease group, cell group and cell class (v2)	ADGRG1 SLAMF1 SYNE2 RPL3 MYBL1	8.61e-05	195	102	5	980909246c30471c9f2f97c3b20b6d6d20fe574e
ToppCell	Healthy-CD4+_CTL\|Healthy / disease group, cell group and cell class	ADGRG1 SLAMF1 SYNE2 RPL3 MYBL1	8.82e-05	196	102	5	9da0ea4ad84d6e20e4349d3d1a8cc4d61d08c84f
ToppCell	BL-critical-LOC-Lymphoid-NK\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ADGRG1 PRKD3 SH2D1B SYNE2 MYBL1	8.82e-05	196	102	5	cfbeaabbeeb197f0cf8240a752d1f2995d59d7b7
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	ATRX CAPNS1 ADGRG1 GNAS MYBL1	8.82e-05	196	102	5	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	mLN-T_cell-gd_T\|T_cell / Region, Cell class and subclass	TET2 ADGRG1 PRKD3 SH2D1B SYT11	8.82e-05	196	102	5	8f476408cd5a4ea9d25c763c66565343d7989b38
ToppCell	Healthy-CD4+_CTL\|World / disease group, cell group and cell class	ADGRG1 SYNE2 RPL3 MYBL1 PDZD4	8.82e-05	196	102	5	6a623eeb2ba8d4e16543820bcbba41eecbd00ed2
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADGRG1 SYNE2 RPL3 MYBL1 PDZD4	8.82e-05	196	102	5	0f3c7fd450aaa1f866b8558692534c0ea2a34e75
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ADGRG1 SYNE2 RPL3 MYBL1 PDZD4	8.82e-05	196	102	5	4e1f8828413896ab8a4ec92a89d6789e8e37e05a
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD16\|lymph-node_spleen / Manually curated celltypes from each tissue	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	8.82e-05	196	102	5	f7e5a7fad4547e8ab9ab8b140239281832fb4260
ToppCell	droplet-Tongue-nan-3m-Epithelial-suprabasal_differentiating\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX GNAS EIF3H RPL3 RPL17	8.82e-05	196	102	5	27364b577d77aefaa147abb346c46fce61e28ec3
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG1 SLAMF1 SYNE2 MYBL1 PDZD4	8.82e-05	196	102	5	60f5deb97f3d6f8422bb5849778205a7022002ae
ToppCell	normal_Lung-T/NK_cells-NK\|normal_Lung / Location, Cell class and cell subclass	ADGRG1 SH2D1B SYNE2 RPL3 MYBL1	9.03e-05	197	102	5	6045a05a5f1073d683806eb46a3fa98358414625
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ADGRG1 SYNE2 RPL3 MYBL1 PDZD4	9.03e-05	197	102	5	2b3a56bb1d40bc1284a5931c4e7b373660de5402
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD8+_Tem\|COVID-19_Severe / Disease group, lineage and cell class	ADGRG1 SYNE2 RPL3 MYBL1 PDZD4	9.03e-05	197	102	5	f0bac4d5c3160933ac3786cec8dadffb35d711ea
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ADGRG1 SYNE2 RPL3 MYBL1 PDZD4	9.03e-05	197	102	5	f73ece3aca28c0db5db0f12e026d42c6c36b9efb
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADGRG1 SYNE2 RPL3 MYBL1 PDZD4	9.03e-05	197	102	5	e70e7d97823a762def3970d94a0e897981a6c922
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	9.03e-05	197	102	5	32b770e403028862f91e4727f4a8fbb6151910e4
ToppCell	Healthy_donor-CD4+_CTL\|World / disease group, cell group and cell class (v2)	SLAMF1 SYNE2 RPL3 MYBL1 PDZD4	9.03e-05	197	102	5	1dee9b905ef36e567acc1094a3c0e41f56d1261e
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADGRG1 SYNE2 RPL3 MYBL1 PDZD4	9.03e-05	197	102	5	bce0135a96910d2bace62a3408a1a6fdac0cf0df
ToppCell	COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	ADGRG1 SYT11 SYNE2 MYBL1 PDZD4	9.03e-05	197	102	5	d4dfb3b561d0783cdbee4e8d27009ad81df695cb
ToppCell	healthy_donor-Lymphocytic-ILC-NK_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	9.25e-05	198	102	5	d7053a898e04478c577381085f615edaad3cdc5b
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	9.25e-05	198	102	5	c54da37aa11f82a68e591d563b3db9121d6b498f
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	9.25e-05	198	102	5	58d805e827299292750b09c6283fdbe406b75f79
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	9.25e-05	198	102	5	90023468f3498548a92d75928f476b4157bde813
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG1 SLAMF1 SYNE2 MYBL1 PDZD4	9.25e-05	198	102	5	a6b942fe850e287e1cb705684e29218072daf891
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ADGRG1 SLAMF1 SYNE2 RPL3 MYBL1	9.25e-05	198	102	5	f77f21f21566a04145217ebf85cd14db48945056
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	9.25e-05	198	102	5	2fdb92b198ba24e326e90479fd024400d956fb32
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK1 ACACA MAGI2 NF1 VPS13B	9.25e-05	198	102	5	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADGRG1 SLAMF1 SYNE2 RPL3 MYBL1	9.25e-05	198	102	5	7f61a9a3d61992c023cc4bc4571a0a7a1a160833
ToppCell	control-Lymphocytic-NK_cells\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	9.25e-05	198	102	5	1c779101d0c5f29de5cc7170d784931d6e34bdcd
ToppCell	healthy_donor-Lymphocytic-ILC\|healthy_donor / Disease condition, Lineage, Cell class and subclass	ADGRG1 SH2D1B SYNE2 MYBL1 PDZD4	9.25e-05	198	102	5	aa33be29e26f1b8facfc894413099083ae3bbb1b
ToppCell	severe-Lymphocytic-CD8_T_cells\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ADGRG1 SYNE2 RPL3 MYBL1 PDZD4	9.25e-05	198	102	5	2cd13418396ab2c53b1be96e7795841c2482bfca
Computational	Steroid hormone and heme metabolism.	UGT2B7 UGT2B10 HSD17B4	1.34e-04	16	69	3	MODULE_505
Computational	Genes in the cancer module 32.	ZC3H11A EIF5 GNAS EIF3H PUM1 RPL3 RPL17 HDLBP	1.46e-04	241	69	8	MODULE_32
Drug	T4-G	TPO UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.81e-08	19	102	5	CID000152424
Drug	butylated hydroxytoluene	CAPNS1 DLK1 PRKD3 KCNMA1 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.65e-07	143	102	8	CID000031404
Drug	testosterone glucuronide	NF1 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.08e-06	41	102	5	CID000108192
Drug	C1 11-32	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.11e-06	18	102	4	CID000443077
Drug	C11131	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.11e-06	18	102	4	CID000443076
Drug	estriol-16-glucuronide	UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.14e-06	21	102	4	CID000122281
Drug	salicylamide	ACACA UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.40e-06	48	102	5	CID000005147
Drug	muconomycin A	DLK1 RPL3 RPL3L	3.02e-06	7	102	3	CID000104830
Drug	estradiol-3-glucuronide	UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.15e-06	23	102	4	CID000066651
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; PC3; HT_HG-U133A	TM7SF3 EVPL MAP3K12 GPATCH2L CSE1L KCNMA1 GNAS EXOC7	3.21e-06	199	102	8	6308_DN
Drug	L-idaro-1,4-lactone	UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.16e-06	28	102	4	CID000078997
Drug	UDP-alpha-d-xylopyranose	ITIH4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.34e-06	60	102	5	CID000001165
Drug	7-hydroxycoumarin glucuronide	UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.27e-06	29	102	4	CID000125641
Drug	lithocholic acid	TPO KCNMA1 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.39e-05	116	102	6	CID000009903
Drug	zomepirac	MAP3K12 UGT2B7 RPL17	1.40e-05	11	102	3	CID000005733
Drug	AC1Q6OQG	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.41e-05	33	102	4	CID000009686
Drug	BP-3,6-quinol	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.41e-05	33	102	4	CID000119292
Drug	AC1NOWCJ	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.79e-05	35	102	4	CID005120112
Drug	3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.79e-05	35	102	4	CID010436171
Drug	estrone-3-glucuronide	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.79e-05	35	102	4	CID000115255
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	UBR2 PUM2 CREBBP ZBED5 RLF AKAP9 PUM1	1.81e-05	182	102	7	3887_DN
Drug	eugenol	KCNMA1 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.93e-05	73	102	5	CID000003314
Drug	2-hydroxyestriol	UGT2B7 UGT2B11	1.99e-05	2	102	2	ctd:C008012
Drug	l-borneol	UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.24e-05	37	102	4	CID000010049
Drug	harmol	UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.07e-05	40	102	4	CID000068094
Drug	Spironolactone [52-01-7]; Down 200; 9.6uM; PC3; HT_HG-U133A	DOCK1 ACVR2B NF1 R3HCC1L GMEB1 GNAS RECK	3.21e-05	199	102	7	5781_DN
Drug	2-AF	UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.38e-05	41	102	4	CID000005800
Drug	androsterone glucuronide	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.10e-05	43	102	4	CID000114833
Drug	7,8-benzoquinoline	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.10e-05	43	102	4	CID000009191
Drug	MS-222	UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.49e-05	44	102	4	CID000011400
Drug	chlorcyclizine	WIPI1 ATRX OMD CREBBP AKAP9	4.51e-05	87	102	5	ctd:C084597
Drug	AC1NQGK1	UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.71e-05	52	102	4	CID005195977
Drug	oxazepam	UGT2B7 UGT2B10 UGT2B28 UGT2B11	9.39e-05	53	102	4	CID000004616
Drug	Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A	ITCH RLF NF1 AKAP9 HELZ PUM1	1.04e-04	166	102	6	5324_UP
Drug	glucosiduronate	TPO DLK1 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.22e-04	171	102	6	CID000000610
Drug	7-methoxycoumarin	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.25e-04	57	102	4	CID000010748
Drug	fenoprofen	MAP3K12 UGT2B7 RPL17	1.26e-04	22	102	3	CID000003342
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	WIPI1 SYT11 CATSPERB RPL3L RECK RAI2	1.30e-04	173	102	6	4112_UP
Drug	phenolphthalein	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.34e-04	58	102	4	CID000004764
Drug	CEP-1347	CAPNS1 MAP3K12 ITIH4 NF1	1.43e-04	59	102	4	CID000133005
Drug	urochloralic acid	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.43e-04	59	102	4	CID003036914
Drug	4-hydroxybiphenyl	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.43e-04	59	102	4	CID000007103
Drug	4-hydroxyestrone	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.43e-04	59	102	4	CID000018418
Drug	acetaminophen glucuronide	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.43e-04	59	102	4	CID000083944
Drug	SN-38G	UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.43e-04	59	102	4	CID000443154
Drug	Phthalic Acids	TPO UBR2 GALNT1 ACACA NSD1 RTN4IP1 ZC3H11A AKAP9 SCARB1 ASXL2 RPL3 RECK	1.55e-04	762	102	12	ctd:D010795
Drug	Ellipticine [519-23-3]; Down 200; 16.2uM; PC3; HT_HG-U133A	PUM2 ZBED5 RLF NF1 EIF5 PUM1	1.61e-04	180	102	6	5779_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	PUM2 CREBBP ZBED5 WDR43 RLF PUM1	1.61e-04	180	102	6	4541_DN
Disease	Adenoid Cystic Carcinoma	ATRX NSD1 ERBIN CREBBP MAGI2 MARK2 MYBL1	5.13e-08	100	100	7	C0010606
Disease	plasma clozapine-to-N-desmethylclozapine ratio measurement	UGT2B7 UGT2B10 UGT2B11	3.13e-06	9	100	3	EFO_0600040
Disease	IGF-1 measurement	H3-5 DLK1 ADAMTS8 BBX SYNE2 ASXL2 GNAS RPL3L HDLBP	4.32e-05	488	100	9	EFO_0004627
Disease	Hematopoetic Myelodysplasia	TET2 ATRX DLK1	1.29e-04	29	100	3	C2713368
Disease	acute myeloid leukemia (is_implicated_in)	TET2 NSD1 CREBBP NF1	1.95e-04	84	100	4	DOID:9119 (is_implicated_in)
Disease	Leukemia, Myelocytic, Acute	TET2 NSD1 CREBBP NF1 ASXL2	3.14e-04	173	100	5	C0023467
Disease	deoxycholic acid glucuronide measurement	UGT2B7 UGT2B10	3.14e-04	8	100	2	EFO_0800575
Disease	Cryptorchidism	ATRX PUM1	5.03e-04	10	100	2	C0010417
Disease	Glioblastoma Multiforme	ATRX PRKD3 NF1 RECK	5.63e-04	111	100	4	C1621958
Disease	sugar consumption measurement	WIPI1 STK33 CATSPERB VPS13B	7.55e-04	120	100	4	EFO_0010158
Disease	X-19141 measurement	UGT2B7 UGT2B11	8.66e-04	13	100	2	EFO_0800799
Disease	Papillary Renal Cell Carcinoma	TET2 SCARB1 SYNE2 KCNMA1	9.60e-04	128	100	4	C1306837
Disease	Renal Cell Carcinoma	TET2 SCARB1 SYNE2 KCNMA1	9.60e-04	128	100	4	C0007134
Disease	Sarcomatoid Renal Cell Carcinoma	TET2 SCARB1 SYNE2 KCNMA1	9.60e-04	128	100	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	TET2 SCARB1 SYNE2 KCNMA1	9.60e-04	128	100	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	TET2 SCARB1 SYNE2 KCNMA1	9.60e-04	128	100	4	C1266044
Disease	vitamin D measurement	WIPI1 DLK1 UGT2B7 UGT2B10 ZNF808 UGT2B11	1.01e-03	336	100	6	EFO_0004631
Disease	alcohol consumption measurement	DOCK1 ACACA ZNF618 NBEA ACVR2B WDR43 MAGI2 NF1 AKAP9 STK33 RCOR3 ASXL2	1.01e-03	1242	100	12	EFO_0007878
Disease	Malignant neoplasm of breast	ANK2 SLAMF1 ZC3H11A NF1 AKAP9 FAM83F SYNE2 EIF5 VPS13B PDZD4 HDLBP	1.04e-03	1074	100	11	C0006142
Disease	myelodysplastic syndrome (implicated_via_orthology)	TET2 CREBBP	1.16e-03	15	100	2	DOID:0050908 (implicated_via_orthology)
Disease	hair colour measurement	ZNF618 PUM2 SCARB1 SYNE2 CATSPERB ASXL2 CPSF2 RPL3	1.18e-03	615	100	8	EFO_0007822
Disease	testosterone measurement	TET2 ANK2 DLK1 GPR83 NF1 BBX SCARB1 SYNE2 UGT2B7 UGT2B10 FAM47E UGT2B11	1.27e-03	1275	100	12	EFO_0004908
Disease	vision disorder	TPO MAGI2	1.32e-03	16	100	2	MONDO_0021084
Disease	Romano-Ward Syndrome	ANK2 AKAP9	1.32e-03	16	100	2	C0035828
Disease	MYELODYSPLASTIC SYNDROME	TET2 ATRX DLK1	1.55e-03	67	100	3	C3463824
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	TET2 SCARB1 SYNE2 KCNMA1	1.64e-03	148	100	4	C0279702
Disease	phosphatidylcholine 36:4 measurement	UGT2B28 UGT2B11	1.68e-03	18	100	2	EFO_0010382
Disease	Malignant Glioma	ATRX NF1 MYBL1	1.75e-03	70	100	3	C0555198
Disease	mixed gliomas	ATRX NF1 MYBL1	1.75e-03	70	100	3	C0259783
Disease	Autistic Disorder	NSD1 NBEA NF1 KCNMA1 HDLBP	1.98e-03	261	100	5	C0004352
Disease	creatinine measurement	TET2 WIPI1 NSD1 ACVR2B KCNMA1 RCOR3 ASXL2 FAM47E GNAS RPL3L	2.03e-03	995	100	10	EFO_0004518
Disease	serum copper measurement	ANK2 KRR1	2.29e-03	21	100	2	EFO_0005267
Disease	X-24947 measurement	UGT2B7 UGT2B11	2.51e-03	22	100	2	EFO_0800910
Disease	Colorectal Carcinoma	TET2 ACACA ANK2 CSE1L NF1 AKAP9 GNAS EIF3H	2.69e-03	702	100	8	C0009402
Disease	malignant astrocytoma (is_marker_for)	ATRX NF1	2.75e-03	23	100	2	DOID:3069 (is_marker_for)
Disease	West Syndrome	MAGI2 HSD17B4	2.99e-03	24	100	2	C0037769
Disease	Brugada Syndrome (disorder)	ANK2 AKAP9	2.99e-03	24	100	2	C1142166
Disease	comparative body size at age 10, self-reported	DLK1 ACVR2B MAGI2 NF1 GNAS EXOC7	3.11e-03	420	100	6	EFO_0009819
Disease	Glioma	ATRX NF1 MYBL1	3.26e-03	87	100	3	C0017638

Protein segments in the cluster

Peptide	Gene	Start	Entry
QRMTVVVLKARHLPK	SYT11	306	Q9BT88
LKPQTVQGHVQLRIM	TTC21B	1111	Q7Z4L5
IALLNVMKERHPQSK	NAIP	1371	Q13075
LKNMVKTVQTIVHRL	ERBIN	491	Q96RT1
VVAQPVHMQQLLKLK	EP400	2956	Q96L91
HLQRINPTTVKMKSS	AKAP9	901	Q99996
VPIVIKNSHLINVLM	EIF3H	201	O15372
RNTMEPVHKVKNIPS	BBX	791	Q8WY36
KHTVPENIKRMKQLV	CATSPERB	986	Q9H7T0
KIINQMKPRQLIIVH	CPSF2	551	Q9P2I0
HPSIKNSINLMVVKV	ADAMTS8	256	Q9UP79
SLPSCQKMKRVVQHT	CREBBP	1791	Q92793
HAQVTKKNLLVTMLI	ACACA	1031	Q13085
PVQQPEHRILKVSMK	DLK1	276	P80370
NTPMSHKEILQVIQR	ASXL2	26	Q76L83
LKVRPQQLVKHLQMD	ITIH4	161	Q14624
LGIKHTMVKIRPLSQ	R3HCC1L	696	Q7Z5L2
KSFHRIQQMLPDKTI	RCOR3	106	Q9P2K3
QEIHMLPIKKQRLAT	RAI2	511	Q9Y5P3
QMKALKHLRQTRTVP	RBM33	906	Q96EV2
LINTHSKMKVSNRRP	NSD1	346	Q96L73
KPITVLEILQKIRMH	RECK	851	O95980
LEILQKIRMHVSVPQ	RECK	856	O95980
QRKIIMHKIRPHITT	PUM2	1016	Q8TB72
QILTPMAQKEAVIKH	PUM3	311	Q15397
RKMVKQVHTALPKVN	KIAA1107	386	Q9UPP5
LQAQPMHSELVKKIL	ANK2	1196	Q01484
QSIINMPHADIVKLI	MAGI2	981	Q86UL8
SIKNYHPKIRIITQM	KCNMA1	511	Q12791
HRLKSQTVQNVVLMP	GMEB1	356	Q9Y692
AIHAKRVTIMPKDIQ	H3-5	111	Q6NXT2
VIAQRLMQSKQTIPH	DLAT	431	P10515
PELNIIALSHRKTMK	PDZD4	716	Q76G19
MKRKVNLKTQQSQHP	TPO	101	P07202
VQLESKRKTMQPHLL	EVPL	1001	Q92817
ASMSQKRLIPHQVVT	NOL6	606	Q9H6R4
NNIPLMRVVQSIKHT	PRKD3	396	O94806
EVRKVVLDTMKNIHP	KRR1	201	Q13601
QVIMHPLKPRISITK	GPR83	171	Q9NYM4
MPQKEDILKHRVVVV	HELZ	756	P42694
SRLMKLENSIIPVHK	EXOC7	51	Q9UPT5
TVPKMLANHILRTQT	OR1F2P	76	Q96R84
QRKIVMHKIRPHIAT	PUM1	1136	Q14671
IQTKVKHRTPMVSVP	OSBPL8	766	Q9BZF1
QITVRTMKPPAKVHI	MYO15B	981	Q96JP2
QLAMPQHIKITVTRK	ITCH	541	Q96J02
VKKLKVPVHVIRMEQ	GALNT1	171	Q10472
KEPLVQVHRNMVIKL	ATRX	1546	P46100
SKVRQKLHIVLCMSP	DNAH6	2566	Q9C0G6
QAQLISKIPHILKEM	EIF5	326	P55010
QLILNHKMEPLQVVK	FBH1	446	Q8NFZ0
VGPTQRHVQIIMEKL	DOCK1	896	Q14185
IVRQKNHPMTPEAVK	HSD17B4	256	P51659
MNILNKVVTRHPDLK	CAPNS1	121	P04632
TMVVQILRLRPHTQK	ADGRG1	591	Q9Y653
KIIHRDLKSPNMLIT	MAP3K12	231	Q12852
VRIMKVLNHPNIVKL	MARK2	101	Q7KZI7
LLKTAQNHPMLVELK	LSM4	6	Q9Y4Z0
TMVAKRHPALNAIVK	GPATCH2L	91	Q9NWQ4
SPIKSTPVKLMRIQH	MYBL1	386	P10243
KMTHRIQAKVEPEIQ	DHRS13	361	Q6UX07
RKLKTIPNIPMHIQQ	OMD	81	Q99983
ATALNMKRDPLHVKI	RTN4IP1	96	Q8WWV3
TMRILSNLVQHILKK	RTP4	111	Q96DX8
HTMKLNQVPLELKRS	FAM47E	251	Q6ZV65
SVLKQLMKVDPAHRI	STK33	356	Q9BYT3
LHQLQMEKLPSRKAI	SYNE2	5051	Q8WXH0
LPLRQKKAHLMEIQV	RPL3	171	P39023
LPFRQKKAHIMEIQL	RPL3L	171	Q92901
TTVPKMLVNIQTHNK	OR7A10	76	O76100
KSTIVKQMRILHVNG	GNAS	696	Q5JWF2
TVKIQNPMILKVVAT	NBEA	836	Q8NFP9
RINKSMNKSIHIVVT	SLAMF1	51	Q13291
LMKIQQLHPANAKTV	SIMC1	531	Q8NDZ2
MVPSLIKQQVLKNVR	SCARB1	31	Q8WTV0
SLVIEHIQVNKAPKM	RPL17	111	P18621
IHLFRTLNPQMLQKK	SDAD1	436	Q9NVU7
KAPHLKQVVRQMIQQ	FAM83F	146	Q8NEG4
QGMVVHLLKPIKRTS	SH2D1B	91	O14796
NPSHQMTKRKRVVLV	CHRM5	421	P08912
ELQEVVVHKKMRPTI	ACVR2B	426	Q13705
IHVLKRDLKMVTAQT	CLEC4F	331	Q8N1N0
SKRQVDIHIMELPKN	RNF17	1316	Q9BXT8
IVHLMLSSPEQIQKQ	CSE1L	96	P55060
AHKVAMILDPQQKLR	ZNF618	801	Q5T7W0
QMRIKHLLKSNCIPQ	RLF	216	Q13129
TNIRPQLHQKSIMKK	RPAP2	236	Q8IXW5
HMQKQQEREKSVLTP	ZC3H11A	566	O75152
SLLPQKQEVHMREKS	ZNF808	216	Q8N4W9
VLGNMVHAIQIKTKL	NF1	1001	P21359
NIMKLSRIQHDQPVK	UGT2B11	441	O75310
RHALAVKIMPTSLKN	ZBED5	376	Q49AG3
IIHNRCPVKMLIKEN	VPS13B	3256	Q7Z7G8
IMKLSRIQHDQPVKP	UGT2B10	441	P36537
SLLPQKQEVHMREKS	ZNF611	216	Q8N823
QMQKHQKVPTAVLLS	XPNPEP2	226	O43895
NLAKITQQMPKVHIE	HDLBP	386	Q00341
LVVVVSHTKPRQMNV	WIPI1	71	Q5MNZ9
NVMKLSIIQHDQPVK	UGT2B28	441	Q9BY64
NVMKLSRIQHDQPVK	UGT2B7	441	P16662
TSRQTKPLKVQVMHS	UBR2	291	Q8IWV8
TEKLMSPVLKQHLNQ	TET2	691	Q6N021
NVNLIKKTVLRMPLH	WDR43	486	Q15061
LLKHLQRMVSVPQVK	TM7SF3	211	Q9NS93